• Welcome To E-Poster Presentations
  • Click Return To Home to navigate back to the first page
Return To Home

E-Presentation

Refresh Page View All

Pretreatment absolute monocyte count is a novel biomarker for predicting worse clinical outcome in chemo-resistant urothelial carcinoma patients treated with pembrolizumab

Paper No: 98 | Oncology - Bladder and Upper Urinary Tract Urothelial Cancer
Koichiro Ogihara

3-Minute Oral Presentation 2 | Oncology (Bladder & UTUC) 2

08 Aug 2019 | 11:30:00-12:30:00

Back to Top